Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
Primary Industries
- Drugs
- Therapeutic
- Assay
- Diagnostic
- Disease
- Drug Discovery
- Viral Infection
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 211862
Licensor has developed, and owns the right to use, certain data and information pertaining to the synthetic steroid Nestorone(R) (17-acetoxy-16-methylene-19-norprogesterone).
Licensor and the manufacturer of Nestorone(R) have entered into an agreement for, among, other things, the supply of Nestorone(R), to manufacturers of products incorporating Nestorone(R), including products for use in the field of human reproductive health.
Nestorone and Elcometrine, is a progestin of the 19-norprogesterone group which is used as a hormonal contraceptive and in the treatment of endometriosis.
Endometriosis is a condition in which the layer of tissue that normally covers the inside of the uterus grows outside of it. Most often this is on the ovaries, fallopian tubes, and tissue around the uterus and ovaries; however, in rare cases it may also occur in other parts of the body.
The tradename registered is Nestorone(R).
IPSCIO Record ID: 255484
LICENSOR is the named assignee for several patent applications including nonprovisional US patent application SIN 12/120,322 to Kenneth Ward entitled 'Method of Administering a Therapeutic'.
Companion Diagnostic Tests mean any Test for the administration of a Therapeutic, the use, sale, or offer of sale of which would, but for this Agreement, constitute an infringement of the Patent Application referred to as 322 or any continuation, divisional, continuation in part, or foreign counterpart application claiming priority to the 322 Application, and any patent that may issue therefrom, collectively, the Test Patents.
Endometriosis is an often painful disorder in which tissue that normally lines the inside of your uterus — the endometrium — grows outside your uterus. Endometriosis most commonly involves your ovaries, fallopian tubes and the tissue lining your pelvis.
IPSCIO Record ID: 288103
During the term of the license agreement and for two years thereafter, Licensee undertakes not to develop or commercialize any product that directly competes with any marketed product that is covered by the licensed technology.
With this agreement, Licensee became the exclusive licensee of 6 U.S. patents, 1 European Patent, 1 PRC patent, 1 Indian patent and 1 Japanese patent, as well as 1 pending US patent application. Two technologies are claimed in the patents Epigallocatechin Gallate Derivatives for Inhibiting Proteasome, and Pro-EGCG.
Endometriosis is an often painful disorder in which tissue similar to the tissue that normally lines the inside of your uterus — the endometrium — grows outside your uterus. Endometriosis most commonly involves your ovaries, fallopian tubes and the tissue lining your pelvis.
